共 31 条
PACS Integration of Semiautomated Imaging Software Improves Day-to-Day MS Disease Activity Detection
被引:7
作者:
Dahan, A.
[1
]
Pereira, R.
[2
,4
]
Malpas, C. B.
[3
,5
]
Kalincik, T.
[3
,5
]
Gaillard, F.
[2
,6
,7
]
机构:
[1] Austin Hosp, Dept Radiol, Lance Townsend Bldg,145 Studley Rd, Heidelberg, Vic 3084, Australia
[2] Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia
[3] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia
[4] Univ Queensland, Dept Radiol, Brisbane, Qld, Australia
[5] Univ Melbourne, Clin Outcomes Res Unit CORe, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[7] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia
基金:
澳大利亚研究理事会;
英国医学研究理事会;
关键词:
MULTIPLE-SCLEROSIS;
LESION LOAD;
FOLLOW-UP;
DISABILITY;
MRI;
SEGMENTATION;
IMAGES;
D O I:
10.3174/ajnr.A6195
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
BACKGROUND AND PURPOSE: The standard for evaluating interval radiologic activity in MS, side-by-side MR imaging comparison, is restricted by its time-consuming nature and limited sensitivity. VisTarsier, a semiautomated software for comparing volumetric FLAIR sequences, has shown better disease-activity detection than conventional comparison in retrospective studies. Our objective was to determine whether implementing this software in day-to-day practice would show similar efficacy. MATERIALS AND METHODS: VisTarsier created an additional coregistered image series for reporting a color-coded disease-activity change map for every new MS MR imaging brain study that contained volumetric FLAIR sequences. All other MS studies, including those generated during software-maintenance periods, were interpreted with side-by-side comparison only. The number of new lesions reported with software assistance was compared with those observed with traditional assessment in a generalized linear mixed model. Questionnaires were sent to participating radiologists to evaluate the perceived day-to-day impact of the software. RESULTS: Nine hundred six study pairs from 538 patients during 2 years were included. The semiautomated software was used in 841 study pairs, while the remaining 65 used conventional comparison only. Twenty percent of software-aided studies reported having new lesions versus 9% with standard comparison only. The use of this software was associated with an odds ratio of 4.15 for detection of new or enlarging lesions (P = .040), and 86.9% of respondents from the survey found that the software saved at least 2-5 minutes per scan report. CONCLUSIONS: VisTarsier can be implemented in real-world clinical settings with good acceptance and preservation of accuracy demonstrated in a retrospective environment.
引用
收藏
页码:1624 / 1629
页数:6
相关论文